1 year ago
Ciltacabtagene Autoleucel EMA is The First CAR-T Cell Therapy to Receive Positive Opinions On February 23, 2024, Legend Biotech announced that the European Medicines Agency’s (EMA) Committee ...
1 year ago
Ciltacabtagene Autoleucel (Carvykti) Approved by FDA for Second-Line Treatment of Relapsed or Refractory Multiple Myeloma Johnson & Johnson and Legend Biotech’s jointly developed chimeric...
1 year ago
Carvykti FDA Approval Press Release,Legend Biotech’s Carvykti Approved in the U.S. for Second-Line Treatment of Relapsed or Refractory Multiple Myeloma Carvykti is approved for second-line tr...
1 year ago
No Tumor Recurrence for Nearly 3 Years, China’s National Research #TIL Therapy #GC101 Targets Various Solid Tumors! TIL Therapy In recent years, immunotherapy has emerged as a pivotal di...
1 year ago
Carvykti EMA Approval for Second-Line Treatment of Multiple Myeloma Carvykti Receives CHMP Recommendation for Approval for Front-Line Treatment of Multiple Myeloma On February 23, 2024, Legend Biot...
1 year ago
Carvykti EU Approval on May 26, 2022 CARVYKTI® (Cilta-cel, Ciltacabtagene Autoleucel) Approved for Marketing in the European Union CARVYKTI® (Cilta-cel, Ciltacabtagene Autoleucel) is the first prod...
1 year ago
Will Carvykti(Ciltacabtagene Autoleucel) become one of the new standards of care for lenalidomide-refractory multiple myeloma Introduction to carvykti Carvykti (Ciltacabtagene Autoleucel, cilta-cel...
1 year ago
✈️ Thumbs Up for Visa-Free Policy: Off to China on a Whim! ✈️ Visa-Free Policy 🌏China expands its unilateral visa-free and mutual visa exemption policy. Starting from March 14, 2024, China implemen...
1 year ago
Research Progress of CAR-T Myeloma Therapy Multiple myeloma (MM) is a malignant plasma cell neoplasm characterized by the abnormal accumulation of monoclonal plasma cells in the bone marrow and the...
1 year ago
Understanding CAR-T Cells and Multiple Myeloma Therapy in One Read Many lymphoma and leukemia patients are familiar with CAR-T cell therapy, but for multiple myeloma patients, CAR-T cell therapy is...
1 year ago
A Successful Case of CAR-T Cell Immunotherapy for Multiple Myeloma in China At the Bone Marrow Transplantation Center of the First Affiliated Hospital of Zhejiang University School of Medicine in C...
1 year ago
🎉💉 Exciting Breakthrough Alert! Chinese Medical Team Unveils Game-Changing mRNA Cancer Vaccine 🎉💉 Advanced Science Say hello to the future of cancer treatment! A groundbreaking mRNA cancer v...
By using our site, you agree to our Terms and Conditions and Privacy Policy.Advanced Medicine In China does not provide medical advice, diagnosis, or treatment. The information provided on this site is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her existing physician.
© Copyright 2023 Advanced Medicine In China. All rights reserved.
